{"id":"W2152718594","doi":"10.1186/1745-6215-11-113","title":"Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial","year":2010,"lang":"en","type":"article","venue":"Trials","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network","funders":"Fundação Oswaldo Cruz; Canadian Institutes of Health Research; Ontario HIV Treatment Network","keywords":"Medicine; Viral load; Clinical endpoint; Herpes simplex virus; Clinical trial; Adverse effect; Asymptomatic; Placebo; Internal medicine; Immunology; Human immunodeficiency virus (HIV); Virus; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04804082,0.003616039,0.004775709,0.0009251764,0.002086415,0.003640225,0.00267201,0.007094231,0.04500894],"category_scores_gemma":[0.02853931,0.002004479,0.003825768,0.001594223,0.002489337,0.002342518,0.002165018,0.006079322,0.01458337],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002931223,"about_ca_system_score_gemma":0.01267905,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001091467,"about_ca_topic_score_gemma":0.003144936,"domain_scores_codex":[0.9739141,0.01878255,0.001701781,0.001812033,0.00212381,0.001665695],"domain_scores_gemma":[0.9891986,0.002178201,0.002456293,0.002283231,0.002074534,0.001809222],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.9024856,0.009671647,0.001302017,0.006095825,0.001742298,0.0001345629,0.0002599625,0.001224755,0.001346298,0.005212479,0.03338761,0.03713687],"study_design_scores_gemma":[0.9427918,0.01299003,0.001599816,0.001181252,0.0005376367,0.00004085047,0.0000447605,0.0007402446,0.0003831887,0.002196817,0.03744351,0.00005012843],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.00684356,0.0009709736,0.004004757,0.001611525,0.001660559,0.9735353,0.004714529,0.0002702545,0.006388488],"genre_scores_gemma":[0.005921563,0.0002727519,0.004184793,0.000816074,0.0002072912,0.985846,0.001011691,0.00002029927,0.001719483],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.04804082,"threshold_uncertainty_score":0.2540672,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1304842989595658,"score_gpt":0.4705293011104295,"score_spread":0.3400450021508637,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}